313235-14-2 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
[4-(4-CHLORO-BENZYL)-PIPERAZIN-1-YL]-ACETIC ACID DIHYDROCHLORIDE is used as a research compound for its potential as a central nervous system (CNS) drug. It is being studied for its potential as an antidepressant, anxiolytic, and antipsychotic agent.
Used in the Development of CNS Drugs:
In the pharmaceutical industry, [4-(4-CHLORO-BENZYL)-PIPERAZIN-1-YL]-ACETIC ACID DIHYDROCHLORIDE is used as a precursor in the synthesis of various CNS-active drugs. Its dihydrochloride salt form improves its water solubility, making it a more viable candidate for drug development.
Used in Antidepressant Research:
[4-(4-CHLORO-BENZYL)-PIPERAZIN-1-YL]-ACETIC ACID DIHYDROCHLORIDE is used as a chemical probe in the development of new antidepressant medications, targeting the underlying biochemical imbalances associated with depression.
Used in Anxiolytic Drug Development:
[4-(4-CHLORO-BENZYL)-PIPERAZIN-1-YL]-ACETIC ACID DIHYDROCHLORIDE is also utilized in the research and development of anxiolytic drugs, aiming to alleviate anxiety disorders by modulating the neurotransmitter systems involved in anxiety.
Used in Antipsychotic Medication Research:
[4-(4-CHLORO-BENZYL)-PIPERAZIN-1-YL]-ACETIC ACID DIHYDROCHLORIDE is employed in the search for novel antipsychotic agents, focusing on the treatment of psychotic disorders such as schizophrenia and bipolar disorder.
Check Digit Verification of cas no
The CAS Registry Mumber 313235-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,2,3 and 5 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 313235-14:
(8*3)+(7*1)+(6*3)+(5*2)+(4*3)+(3*5)+(2*1)+(1*4)=92
92 % 10 = 2
So 313235-14-2 is a valid CAS Registry Number.
313235-14-2Relevant academic research and scientific papers
Benzylpiperazinyl-indolinylethanones
-
Page column 27, (2010/11/30)
Disclosed are benzylpiperazinyl-indolinylethanone compounds which are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents. Pharmaceutical compositions, including packaged pharmaceutical compositions, are further provided. Compounds of the invention are also useful as probes for the localization of GABAAreceptors in tissue samples.
